quick search
Today:
Home Business

More Articles

SONGMICS HOME Reforms Furniture Assembly with Innovative TOOLLESS Technology

Sep 11, 2024

PARIS,Sept. 10,2024-- The global-leading online furnishings brand SONGMICS HOME proudly participated in the Maison&Objet 2024,from September 5-9. As an Official Partner,SONGMICS HOME made a signif

Xinhua Silk Road: Seraphim supplies 776 MW solar modules for SW. China's Yunnan to empower green energy development

Sep 11, 2024

BEIJING,Sept. 10,2024-- World-leading solar product maker Seraphim recently announced its 776 MW high-efficiency solar PV project portfolio under construction in southwest China\'s Yunnan Province.

Vooglam Celebrates 7th Anniversary with Special Promotions and Activities

Sep 11, 2024

AUSTIN,Texas,Sept. 11,2024-- Vooglam,a leader in stylish eyewear,is celebrating its 7th anniversary from September 10 to September 24,2024. Over the past seven years,Vooglam has gained a loyal custom

Finance Meets Technology: Unlocking Future Investment at VIFS 2024

Sep 11, 2024

VANCOUVER,Sept. 10,2024-- In the ever-evolving global economy,challenges and opportunities coexist,leaving investors to ask: how can one stay ahead in such a dynamic market? The 2024 Vancouver Interna

Sands China Ltd. Macau Open Badminton 2024 Tournament Coming in September

Sep 11, 2024

Co-organised by Sands China Ltd. and the Badminton Federation of Macau in celebration of dual anniversaries

Study Shows Ubie Symptom Checker Accuracy Rivals Physicians, Outperforms Competitors In Providing Disease Information

Sep 11, 2024

Results show Ubie\'s differential diagnosis platform had a Top-5 hit accuracy of 63.4% and a Top-10 hit accuracy of 71.6%; median physician accuracy was 72.9%

Innovent Delivers Oral Presentation on Phase 1 Clinical Data of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Advanced Non-small Cell Lung Cancer at the 2024 WCLC

Sep 11, 2024

SAN FRANCISCOand SUZHOU,China,Sept. 11,2024-- Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical company that develops,manufactures and commercializes high-qu

'Highly Accurate': Telix's Phase III ZIRCON Trial for Kidney Cancer Imaging Published in The Lancet Oncology

Sep 11, 2024

MELBOURNE,Australia,Sept. 11,2024-- Telix Pharmaceuticals Limited (ASX: TLX,Telix,the Company) today announces that primary results from its Phase III ZIRCON[1] trial have been published in The Lance

BBH Annual Greater China ETF Investor Survey: ETF Assets reach record highs as Greater China propels ETF investment in APAC

Sep 11, 2024

77% of investors predict they will increase their use of ETFs in the next 12 months. HONG KONG,Sept. 11,2024-- Exchange Traded Fund (ETF) asset growth has hit new highs in the Greater China region,wit

PointGuard Energy Leads the Charge with Innovative Solutions at RE+

Sep 11, 2024

LOS ANGELES,Sept. 11,2024-- PointGuard Energy participated in RE+ 2024,the largest solar event in the U.S.,unveiling its advanced energy solutions tailored for the North American market. Featured at t

1 ... 101 102 103 104 105 106 107 ... 132

Quick Search

Official Affairs is a reliable source for the latest regional news, corporate updates, and official announcements, providing unbiased reporting and in-depth insights into corporate affairs.

© OfficialAffairs